Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity.
Mengdie YangHaipeng LiuJingjing LouJiajia ZhangChangjing ZuoMengqin ZhuXiaoyi ZhangYuzhen YinYu ZhangShanshan QinHan ZhangXin FanYifang DangChao ChengZhen ChengFei YuPublished in: Small (Weinheim an der Bergstrasse, Germany) (2023)
Radium-223 ( 223 Ra) is the first-in-class alpha-emitter to mediate tumor eradication, which is commonly thought to kill tumor cells by directly cleaving double-strand DNA. However, the immunogenic characteristics and cell death modalities triggered by 223 Ra remain unclear. Here, it is reported that the 223 Ra irradiation induces the pro-inflammatory damage-associated molecular patterns including calreticulin, HMGB1, and HSP70, hallmarks of tumor immunogenicity. Moreover, therapeutic 223 Ra retards tumor progression by triggering pyroptosis, an immunogenic cell death. Mechanically, 223 Ra-induced DNA damage leads to the activation of stimulator of interferon genes (STING)-mediated DNA sensing pathway, which is critical for NLRP3 inflammasome-dependent pyroptosis and subsequent DCs maturation as well as T cell activation. These findings establish an essential role of STING in mediating alpha-emitter 223 Ra-induced antitumor immunity, which provides the basis for the development of novel cancer therapeutic strategies and combinatory therapy.
Keyphrases
- nlrp inflammasome
- rheumatoid arthritis
- cell death
- disease activity
- dna damage
- ankylosing spondylitis
- high glucose
- single molecule
- diabetic rats
- oxidative stress
- circulating tumor
- cell free
- dendritic cells
- gene expression
- squamous cell carcinoma
- stem cells
- endothelial cells
- genome wide
- poor prognosis
- radiation therapy
- transcription factor
- replacement therapy
- circulating tumor cells
- nucleic acid